World Health Organization : Year 1997 ; World Health Organization, Prevention of Blindness, Global Elimination of Blinding Trachoma, No. 97.1: Report of the First Meeting of the World Health Organization Alliance for the Global Elimination of Trachoma

By Victoria Sheffield

Book Id: WPLBN0000148989
Format Type: PDF eBook
File Size: 0.2 MB
Reproduction Date: 2005

Title:	World Health Organization : Year 1997 ; World Health Organization, Prevention of Blindness, Global Elimination of Blinding Trachoma, No. 97.1: Report of the First Meeting of the World Health Organization Alliance for the Global Elimination of Trachoma
Author:	Victoria Sheffield
Volume:
Language:	English
Subject:	Health., Public health, Wellness programs
Collections:	Medical Library Collection, World Health Collection
Historic Publication Date:
Publisher:	World Health Organization


Citation APA MLA Chicago Sheffield, V. (n.d.). World Health Organization : Year 1997 ; World Health Organization, Prevention of Blindness, Global Elimination of Blinding Trachoma, No. 97.1. Retrieved from http://gutenberg.cc/

Description
Medical Reference Publication

Excerpt
of the Trachoma Alliance. In July 1996, WHO hosted a Global Scientific Meeting on Future Approaches to Trachoma Control which had proposed the integrated SAFE strategy for trachoma control (S for Surgery, A for Antibiotic treatment, F for Facial cleanliness, E for Environmental improvement). A Planning Meeting of Interested Parties held in November 1996 had taken further the formation of the Trachoma Alliance. The challenge now before the new group is to obtain the necessary data from countries with endemic trachoma, to coordinate activities and to mobilize resources to assist national governments with trachoma control programmes as part of primary health care. Mr R. Porter, Executive Director of Sight Savers International, and Dr L. Pizzarello, Medical Director of Helen Keller International, served as Chairman and Vice-Chairman respectively with Dr A. Foster, Medical Director of Christoffel-Blindenmission e.V., as Rapporteur. The draft agenda (Annex 1) was adopted without modification; the list of participants is included in Annex 2.

Table of Contents
TABLE OF CONTENTS INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 I. REVIEW OF FOLLOW-UP ACTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 1.1 Activities of the World Health Organization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 1.2 Activities of the Alliance Members . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 1.2.1 Al-Noor Foundation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 1.2.2 African Medical and Research Foundation (AMREF) . . . . . . . . . . . . . . . . . . . . . 4 1.2.3 Christoffel-Blindenmission e.V. (CBM) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 1.2.4 The Edna McConnell Clark Foundation (EMCF) . . . . . . . . . . . . . . . . . . . . . . . . . 5 1.2.5 French Ministry of Cooperation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 1.2.6 Helen Keller International (HKI) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 1.2.7 The International Agency for the Prevention of Blindness (IAPB) . . . . . . . . . . . . 6 1.2.8 International Eye Foundation (IEF) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 1.2.9 Organisation pour la Prévention de la Cécité (OPC) . . . . . . . . . . . . . . . . . . . . . 7 1.2.10 Sight Savers International (SSI) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 1.2.11 Swiss Red Cross . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 1.2.12 The University of Rome/Italian Ministry of Cooperation . . . . . . . . . . . . . . . . . . . . 9 1.2.13 The World Bank . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 II. UPDATE ON AZITHROMYCIN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 2.1 Resistance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 2.2 Field trial in Morocco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 2.3 Partnership formula in Morocco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 2.4 Community intervention: experience from Tanzania . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 2.5 Use of azithromycin in Australia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 III. RAPID ASSESSMENT OF TRACHOMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 3.1 What is Trachoma Rapid Assessment (TRA)? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 3.2 The preliminary assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 3.3 The rapid survey . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 3.4 Validation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 3.5 Manual . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 IV. GEOGRAPHIC INFORMATION SYSTEM (GIS) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13